Inovio Pharmaceuticals Inc vs Illinois Tool Works Inc. — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Illinois Tool Works Inc. trades at $271.88 (market cap $78.17B). The key difference: Illinois Tool Works Inc. is far larger — about 875.7× Inovio Pharmaceuticals Inc's market cap, and Illinois Tool Works Inc. pays a 2.37% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | ITW | |
|---|---|---|
Market Cap | $89.27M | $78.17B |
Sector | Health | Industrials |
52-Week High | $2.87 | $299.60 |
52-Week Low | $1.05 | $241.07 |
Enterprise Value | $60.28M | $86.49B |
Dividend Yield | — | 2.37% |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →